NCT01579955
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
Clinical trial condition
Congenital Bleeding Disorder
Explore clinical trials studying Congenital Bleeding Disorder. Study availability and eligibility vary by location and protocol.
85 public trials
0 recruiting studies
Congenital Bleeding Disorder trial results
NCT01579968
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
NCT00713648
- Conditions
- Congenital Bleeding Disorder, Congenital FXIII Deficiency
- Locations
-
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Orange, California, United States
- Novo Nordisk Investigational Site Tampa, Florida, United States
- Novo Nordisk Investigational Site Atlanta, Georgia, United States
NCT01322620
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +14 more
- Locations
-
- Novo Nordisk Investigational Site Mississauga, Canada
- Novo Nordisk Investigational Site Madrid, Spain
- Novo Nordisk Investigational Site Crawley, United Kingdom
NCT01365520
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Kuala Lumpur, Malaysia
- Novo Nordisk Investigational Site London, United Kingdom
- Novo Nordisk Investigational Site London, United Kingdom
Completed
Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects
NCT00837356
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Berlin, Germany
- Novo Nordisk Investigational Site Hanover, Germany
- Novo Nordisk Investigational Site Tel Litwinsky, Israel
- Novo Nordisk Investigational Site Florence, Italy
NCT01692925
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Berlin, Germany
- Novo Nordisk Investigational Site Frankfurt/M., Germany
- Novo Nordisk Investigational Site Riga, Latvia
- Novo Nordisk Investigational Site Kuala Lumpur, Malaysia
NCT01205724
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Iowa City, Iowa, United States
- Novo Nordisk Investigational Site Lexington, Kentucky, United States
- Novo Nordisk Investigational Site Baltimore, Maryland, United States
- Novo Nordisk Investigational Site Philadelphia, Pennsylvania, United States
NCT01238367
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Itabashi-ku, Tokyo, Japan
- Novo Nordisk Investigational Site Kashihara-shi, Nara, Japan
- Novo Nordisk Investigational Site Maebashi-shi, Gunma, Japan
- Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan
NCT00956345
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
- Locations
-
- Novo Nordisk Investigational Site Cincinnati, Ohio, United States
- Novo Nordisk Investigational Site Portland, Oregon, United States
- Novo Nordisk Investigational Site Richmond, Virginia, United States
- Novo Nordisk Investigational Site Copenhagen, Denmark